Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't ever forget why we are here and know what you own.
HemaXellerate Iâ„¢ is a patient-specific composition of cells that have previously been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company, together with an internationally-renowned group of stem cell researchers, recently published the scientific basis for the HemaXellerate Iâ„¢ product which may be found at http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf.
"Currently patients with aplastic anemia who are resistant to drugs and ineligible for bone marrow transplant have no therapeutic options. We are fortunate to be in the position to have developed a novel approach to potentially treat this terrible condition," said David Koos, CEO of Bio-Matrix. "To our knowledge the HemaXellerate Iâ„¢ product is the only therapy that has potential to simultaneously block the underlying cause of aplastic anemia while at the same time rebuilding the bone marrow tissue that has been damaged by the disease."
If the clinical trial is successful, the company plans to expand use of HemaXellerate Iâ„¢ to other conditions associated with bone marrow dysfunction, with the overall goal of entering the hematopoietic growth factor market. This market is substantial in size and currently includes drugs such as Neupogen®, Neulasta®, Leukine® and Revolade®.
"Current drug-based approaches for healing bone marrow damage involve "flooding" the body with growth factors, which is extremely expensive and causes unintended consequences because of lack of selectivity," said Dr. Vladimir Bogin, CEO of Chromos Pharma (a contract research organization), which collaborated with Regen on filing the IND and member of the Company's Scientific Advisory Board. "Based on our data HemaXellerate Iâ„¢ possesses the advantage delivering an optimized cellular mixture that produces the needed growth factors at the specific location in the bone marrow niche."
The planned clinical trial anticipates recruiting 10 patients who have failed standard of care, which will be treated with HemaXellerate Iâ„¢ and followed for safety parameters and signals of efficacy. Therapeutic effects will be quantified based on immunological measurements, as well as improvement in blood counts. Patients in the trial will be assessed for one year, however, because the trial is unblinded, data will be available as the study progresses.
Great attitude!
"I have learned from experience that the greater part of our happiness or misery depends on our dispositions and not on our circumstances."
"If your ship doesn't come in, swim out to it."
GLTYA BMSN the BOMB
Nice! SKTO gonna be huge...
Maybe they are outsourcing this function.... BMSN will be fine and will recover soon for all of the longs!
BMSN Now and forever.....
Maybe a Chuck Norris with Stemintense! That would be awesome, he is ageless.
Go MDIN
Everyone, The fish waste would be used for fertilizer to the mj plants. Look at symbol EX*T MJ stock and check out what they are selling... It is a system that takes the waste and delivers it to the plants.This at least is the rumblings.
SKTO is gold
SKTO has proven there are so many liars out there bas*ing this company. We are gettin last laugh...BWAHAHAHA
Looks like we can now do that on our brand new 40 acres of land and soon to be growing facility.... lovin life SKTO$$
That my friend is an enormous amount of DD! I am glad you are on our side...lol Great Job!
All the stars are lining up and will not take too much longer to make everyone a lot happier!
Go SKTO$$
The dispensary name that comes to my mind is "wegonetobank"
The latest message from the company is that SKTO has been busy contacting medical practices where it could potentially supply medical marijuana. The future will show how this would affect the balances of the company, but so far, SKTO has the following resources:
SKTO hopes to remedy this situation by reportedly contacting hospices and similar medical practices, ensuring $30 million of contracts in 2013. The income should come from its newly acquired subsidiary, Medical Greens. As a constant negative, SKTO will meet even greater competition as medical marijuana companies actively build their distribution network in the states where therapeutic usage is allowed.
Wont be released until the Fins come out and then we are all going to sing Kumbaya and smoke a J! Go SKTO
SK3 Group, Inc. (OTC Pink: SKTO) today announces that its newly acquired subsidiary, Medical Greensâ„¢, has contracted for over $30 Million in annual licensing, management, and logistic services from collectives throughout California, after only its first full week of operations under SK3 Group, Inc. "Our team has been exceptional in establishing new client relationships, as we have assembled a complete state-of-the-art service package for the collectives we will manage and consult," states Kevin Allyn, Chairman of SK3. "We have teamed up with top industry experts to offer the highest quality of service and experience for our clients. Currently, we are working with several additional collectives in transitioning their current services and operations into Medical Greensâ„¢."
Recently, SK3 announced that it has shifted its business model to focus purely on the medical marijuana space with the acquisition of Medical Greensâ„¢, a business that currently provides licensing, management, and logistic services for medical marijuana collectives throughout California.
SK3 Group, Inc. (OTC Pink: SKTO) today announced that it has recently contracted over a dozen healthcare facilities and providers in Southern California to become their Medical Cannabis Administrator (MCA). "Medical marijuana eases the suffering of our patients," says Armen Kazanchian, M.D. Ph.D. "With our relationship with Medical Greens, we will be able to better administer this important treatment to our patients." SK3 indicates that it will continue to aggressively seek new contracts with medical facilities and providers throughout California.
About SK3 Group, Inc.
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Who says they have contracts in just California??? Are there not 20 states now that have approved for Medical as well? 2 states totally legal but maybe they are in with medical use only too... Thoughts?
In no way am I sitting on the sidelines for this one!!!!
Shorties gonna fry!!! ha
We can't blame you if you want to get in this morning... Probably one of you best decisions you could make.
Just called this WalMart and Pharmacy said that Snorenz is not on their shelves. : (
http://www.yelp.com/biz/wal-mart-seneca-falls
How about Carrie Underwood?
http://a1.ec-images.myspacecdn.com/images02/6/38b0e172e4d540ccbb004751ee6250a9/l.jpg
Again, it is great to hear the voice of reason. Member mark for Dr, V! and BMSN
Finally a voice of reason! Best post today
Everyone seems to be falling right into the Bear trap! I once thought this board was one of the better ones and long and strong. Can not believe everyone talking about sellin! Right now the Bears are laughing their A$$ off at people acting like this.
If it takes a year or two who cares. BMSN will prevail and so will the Bears that steal your shares in the morning when you sell.IMHO
BMSN Long
His entire math is way off, even if he sold 1,500,000 with a .005 per share profit it would not add up to $65,000.
You have to ignore these folks and know what you own
MDIN
For the three months Ended
March 31, 2013 March 31, 2012
TotalRevenue (Note 1) 5,658,047 0
Cost of Revenue 1,810,575 0
Gross Profit 3,847,472 0
Operating Expenses
Research and Development 83,471 0
Sales, General and Admin. 2,320,130 0
Non-recurring items 132,617
Other 0 0
2,536,218
Operating Income 1,311,254 0
Net Income From Continuing Operations
Add'l Income/Expense Items 1,500 0
Earnings Before Interest and Tax 1,309,754 0
Interest Expense 27 0
Earnings Before Tax 1,309,727 0
Income
Tax 328,112 0
Net Income Cont. Operations 981,615 0
Net Income 981,615 0
WOOHOO!
HOLBROOK, N.Y., April 8, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTCPink: MDIN), today announced that the company has released its quarterly disclosure document, which is the first that shows significant revenue in several years. The disclosure outlines sales revenue in the millions from a variety of sources including direct to consumer sales, and wholesale distribution agreements, and shows that Northstar is a viable business once again.
Since the company's fiscal year starts in September, this is actually the second quarter for Northstar in 2013, but some may argue it is the most important quarter in the company's history. Since the company re-started production of its popular anti-snoring product, Snorenz, its quarterly statements have shown no sales, and only small losses, but like a racehorse leaping out of the gates, the company went from generating nothing at all to several million dollars in sales and distribution agreements. How the products sells-through on a large scale will determine the company's long term profitability, but after a full quarter of selling products to a smaller audience through the internet and a sprinkling of retail locations, the feeling is that projections to date have been conservative. The next big growth spurt for Northstar is expected to be in June and July when major retailers re-work their shelf plans and add new products. Northstar plans to have its products in those new plans, growing from a small number of retailers and Internet sites to thousands or tens of thousands of locations globally.
Northstar's CEO, Nicholas Chieco commented, "I couldn't be prouder of what we have done here. Hard work has paid off and we can finally show all the naysayers what we are capable of. The proof is in black and white, people want our patented products, and we will work as hard as we need to in order to get them to the masses." Mr. Chieco also wants to remind everyone that while the first surge of wholesale orders consists of a larger than ordinary number of units needed to get the product initially stocked, that the company is still selling only a tiny percentage of the retail outlets possible, so there is plenty of room to grow and gain market share. Why does Snorenz command such strong consumer interest? The company maintains that since they own the patent on all natural anti-snoring spray, there is no other product like it on the market. The same holds true for the rest of the company's unique alternative healthcare products.
Anyone interested in Northstar's actual sales numbers and net profits can look at the company's second quarter 2013 disclosure on otcmarkets.com and for more information call Jennifer at 877-571-4387 or email investors@northstarbb.com
About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz©, a patented spray for snoring relief and Stem-Intense, a unique stem cell replacement therapy supplement. Most of the company's products use a unique spray delivery system, and have received very positive consumer reviews all over the world, selling millions upon millions of units from 1996 to the present.
I know I have read a lot about this Q2 statement for breast cancer drug:
We plan to in-license the patent portfolio in Q2 of 2013
There are folks saying it is next years Qtr 2 but it does state Qtr 2 of 2013
So should we believe it started in Jan/March 2013???
Or is it Calendar Qtrs and that would be Apr-June 2013?
Thanks for anyone's feedback
BMSN Loooonnnnngggg$$$$
Agreed! The best thing is no capital gains tax!!!! Woo Hoo
BMSN$$$$$
Sometimes a man's gut tells it all! : ) member marks are flying.....
BMSN$$
Here's your post from Wednesday : ) Good call!
BMSN now LLLLOOOOONNNNNGGGGGG!$$$$
Thanks for the info.
MDIN$$
So does that mean total revenue $45,000,000/238,000,000 shares? (Float)
estimate of $0.18 pps?
My bad... When did their Fiscal year start? october?
Thanks,
MDIN$$$
Nick did say around 5mil but his projections for qtr 2 was double that or more as you can see below. This was without and potential Europe projections. It's nice just to daydream a little I have to admit... MDIN$$$$
This was a post from Dangusbeerbelly and mentions the 5mil in this qtr.
Email from Nick:
Greg,
My apologies if it came off that way. Let me write you a detailed explanation and if you want to take it upon yourself to explain it to some of the other shareholders that you trust, you can. I give you permission to share my views with others.
In no way did I want it to sound like it wasn't a top priority. We have answered comments from DTCC seven times now and every-time we send them back documentation we come closer and closer to getting it lifted. The fact of the matter is that the previous management (Previous to Ray Barton) really did some stupid things and issued stock like it was cotton candy. Worse yet they made a deal with the devil (NIR Group) and really ended up in the jaws of a nasty toxic financing. Billions and billions of shares issued across five companies over a three year period is a red flag to the DTCC and they want us to prove it was all done legally and every share is accounted for.
Fortunately MedGen did keep good records so we have what they need, but they don't even know what they need until they look at it. Each answer we send spawns five more questions so it's been a very trying ordeal. I have hired an accountant/attorney to handle it full time, and as soon as humanly possible, it will be lifted. Is there a possibility that we cannot lift it? I've been told by two separate lawyers that is not going to happen. Our corporate/SEC counsel has removed chills from several companies [some very recently], so he knows.
A separate but still related issue is the Nevada issue and that is also quite complicated. The state of Nevada requires you to pay a fee based on the authorized shares you have whenever you default. In 2011 the company defaulted and paid $21K in fees and immediately asked for a reduction in authorized to 900 mil shares. This would make any future default fees around $2500. For some reason this was never done and in 2012 the company defaulted again. Now they want another $21K to fix the status, and it's simply not fair. We have the proof that we requested the change properly, and they are saying we were notified that they needed a different request on letterhead, which we never received. So, we have been negotiating with them to fix this problem, which must be fixed for the chill to come off. It's not the thing holding it up, it's just the last thing we will have to do, and for now we are focussing on the documentation I mentioned.
Now, we have almost $5mil in revenue this quarter. I am very very happy, and we have the money to pay the bill, although that revenue has to go right back into purchasing inventory for the next quarter (which should be double that, or more if I can purchase enough inventory). When it comes down to the Nevada status being in our way to lift the chill, then of course, I'll authorize it to just be paid and that's that. But while we focus on the documentation of previous issuances, we may as well fight Nevada on our cause, which I believe to be a just one. The best case scenario is that we convince them and save $21K for additional inventory, worst case, I just pay it.
I just want to let people know that we are in no danger of being shut down or halted because of it. We operate under a subsidiary corporation and the sub's business license is just fine. It's not the best thing in the world to have the parent corp. in a "revoked" status but it does no harm to the actual business either. Especially if we can possibly save the company $21K for advertising etc.
Lastly, when I say the stock price is of no consequence to us, or we don't care about it, I am not meaning to come off as though I could care less…What I mean is that we currently fund this business organically, and NOT using the securities. This is great news for shareholders. It is because of this, that should I have to choose where to use money and resources, I have to lean towards business building expenditures in place of something that will boost the equity. I care very much for the men and women who put hard earned money into MDIN. I know all too well how very hard it is to earn a dollar in the current economy, and I know people bought MDIN because they believe in what we are doing and believe it or not that is on my mind constantly. However, if I put all of our resources into fighting VNDM [ or blocking old shares from being freed up], or other things that would make the stock go up, I would be selling the shareholders short. They would be getting an increasing stock based on emptiness. Empty stocks eventually cave-in no matter how hard you fight it. As a shareholder, I know all you want is for the stock to go up…but at what cost? Thats why my view is that my number one job is to build the business. Build it and they will come, right? Will the stock do as well-as fast, no. BUT at least when it does happen, it's there for a reason, so it'll stay there. So, maybe it takes a year to get to five cents, but when you exit, it will not plummet. It will sustain itself because it's based on a strong revenue generating business. Not technical aspects of the securities. I almost feel like I'm doing it for the shareholder's own good. They will thank me later if they hang on now.
Sure If we focussed on the stock 100% (the chill, VNDM, providing "proof" to the public, PR's, etc. etc.) we could get it to a penny in a very short time. But, then we would tank like every other company that trades on a business that is not yet there and never will be there because management is looking at the wrong bullseye. SO, I try to do the best I can to tighten up the equity side of this thing, and focus most of our resources on building this business into a global leader. I think we can do it. Maybe I'm nuts but I really do believe it. It isn't going to happen over night though.
I hope that sheds some light on the subject and why I've done some of the things i've done. I am not explaining this to you so you'll run to post it on the "boards" to make the stock go up…I'm doing it so you can rest knowing that I take your investment very very seriously, and I take my responsibility to protect that investment most seriously of all.
Have a great day.
Nicholas Chieco
Chief Executive Officer & Chairman of the Board of DirectorsNorthStar Global Business Services, Inc.
MedGen, Inc. (Wholly Owned Subsidiary)
A Public Company (PinkSheets: MDIN)
20 Peachtree Ct. Ste 103 | Holbrook, NY 11741
TF: 1-877-571-4387
FX : 1-877-571-6184
nchieco@northstarbb.com
I think you are trying to say we are going back down tomorrow???? If so please sell because you should not be here. If you are not saying this than I apologize for thinking that and some other thoughts..
BMSN
Yesterday you called this a pos and convinced others to sell their positions. How can you now be pumping? You may need a Zanex before this BMSN run is over lol
Why are you not bashing this today? See what a little patience will do for BMSN holders?
That is awesome! Changing lives in more ways than one. Thanks for sharing.
GO BMSN!!!!
That would be great in between all of the future MDIN excitement!!! GLTY
Can you use Fidelity? I bought 300k so far from them with no issues.
Good Luck